Together, we can help make healthcare work better for everyone

Our Clinical Research team partners with scientists to make clinical research trials safe and easy to participate in. By including real, diverse people like you, we can help create medicine that works better for everyone.

Carbon Health is a nationwide, outpatient primary and urgent care provider dedicated to increasing access to high-quality care. As part of this mission, Carbon for Research (C4R) seamlessly integrates clinical trials into every day patient care, shaping a future of medicine that works for everyone.
Across our 90+ owned and operated locations across the country, we meet patients in their communities. Our centers conduct end-to-end studies, refer patients seeking care in real time, and coordinate trial operations across multiple geographies all led by experienced researchers from leading AMCs.

Our approach is inclusive, effective and rewarding.

Join Research Studies
to improve healthcare for yourself & future patients
Access New Treatments
& check-ups from your care team during the study
Receive Compensation
for your time & active engagement

Browse a few of our current trials

Click on the buttons for more info ABOUT EACH STUDY

Where do we conduct research?

With 90+ locations nationwide, we recruit volunteers who reflect real communities. Some sites serve as research hubs, supporting
nearby locations.

Didn't find the right fit? Join our research community to be first in line for future studies:

Frequently Asked Questions

FAQs

  • Can a clinical trial help with a current issue?
    Yes, clinical trials can often provide early access to a new intervention that is generally not available outside of the study. For example, trial participants may be the first to benefit from a new treatment, or gain information about their health status and health risks they wouldn’t otherwise have. 

    In early clinical studies, the safety, side effects and effectiveness of the intervention are still being ascertained. Despite all the research leading up to the trial (including earlier phases), there is always a chance that therapy will not work, could cause certain side effects, or ultimately not be approved by the FDA. In randomized studies, patients cannot choose which group they are assigned to; in blinded studies, patients do not know which intervention they are receiving (or, in some cases, whether they are receiving a placebo). 

    While being in a trial cannot always guarantee immediate effects, the advances made in medicine through this process will benefit your future health and others around the world.
  • Are clinical trials safe?
    Clinical trials are designed with strict safety measures to protect participants. Many years, even decades, of pre-clinical benchwork and animal testing are conducted before an intervention ever reaches a patient. The research field follows strict processes and rigorous protocols reviewed by regulatory agencies like the FDA, ethics committees, experts in the field, and external data safety monitoring boards (who do not have a financial interest in the study) to ensure risks are minimized. 

    Participants are monitored closely, and trials can be stopped if unexpected safety concerns arise. Before joining, participants receive detailed information about potential risks and benefits through the informed consent process.
  • Can anyone participate in a trial?
    Anyone can participate in a trial if they have the condition the therapy, vaccine, diagnostic, or device is intended to treat. Every trial has a strict, predetermined, and specific set of inclusion and exclusion criteria which may include aspects of medical history, demographics, medications, physical exam findings, labs, or imaging.  In order to participate in a trial you must satisfy all of these criteria.
  • Can I change my mind? What are my rights?
    Being in a clinical trial is an elective choice. Just like when joining, you are free to leave whenever you want. If you choose to leave a trial, the clinical trial team may want to know the reason for leaving and whether it has to do with a side effect, new medical issue, life event, or other reason so they can safely monitor, document, and report any information which may impact others. The team may discuss the option to remain in the study for safety monitoring purposes even if you choose to no longer receive the intervention.
  • Do I need to pay for this?
    No. All visits and procedures that are directly related to the study are covered by the trial. No out of pocket costs or insurance is billed for the trial. However, any medical needs that are determined to not be related to the study would require standard of care payments.

    Moreover, you may be reimbursed for time & effort, travel, or mileage depending on the study.

Meet our research leaders

Aaron Weinberg, MD
VP of Medical for
Clinical Research
Niree Hindoyan
Director of Operations
for Clinical Research
Christina Solomon
Head of Strategy

A sample of our published work


Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age (link)

MDPI. 15 February 2025.

Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assays (link)

ASM (American Society for Microbiology) journal. 11 february 2025.

Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial (link)

Clinical infectious diseases. 19 july 2023.

What makes us different

10+ Therapeutic Areas
with a focus on common
conditions that impact a
general medicine population
Acute care conditions
Cardiovascular
Dermatology
Devices
Diagnostic
Endocrinology
Gastroenterology
General internal medicine
Infectious diseases
Metabolic
Obesity medicine
Respiratory
Rheumatology
Vaccines
56% more diverse
Our trial participants are more likely to be non-white than FDA averages. Also, 97% of our participants are new to clinical research.
90+ locations
We conduct research at sites where patients already seek care, complementing research with the capabilities of a community-based healthcare provider
Startup < 1 month
Our central research team streamlines your processes. One point of contact, one budget, one contract for our full network.  Coordinated startup and ongoing operations across the geographies throughout the entire trial invites easy scalability. Multi-tiered systems to ensure the highest quality patient safety and data

Our partners include: